Dust mite allergy shot therapy for kids with rhinitis or asthma
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 5 and 18 years old.
- Your child has allergic rhinitis or asthma caused by dust mites, shown by a positive skin test or a blood test (IgE level at least 0.70 kU/L).
- Your child has had a special blood test that identifies exactly which dust mite proteins they are allergic to.
- If your child has asthma, it must be well-controlled based on standard asthma guidelines.
- Your child is already getting dual-mite allergy shots (subcutaneous immunotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether heating tissue in the nose (radiofrequency ablation) followed by allergy treatment under the skin (immunotherapy) can reduce long-lasting nasal congestion from dust mite allergy. It may help patients whose symptoms are severe and who have not been able to get enough relief with recent allergy medicines.
This study observes how well patients tolerate a specific updosing plan for a house dust mite allergy treatment (Novo-Helisen Depot). It includes children, teens, and adults who are already getting the treatment as part of normal care.
This trial tests a spray placed under the tongue to treat allergic rhinitis caused by dust mites, pet dander, or mold. It looks at how the spray affects the bacteria in your nose and body.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Rhinitis Due to House Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.